Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

Eun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, Alexandra Kruse, Craig Kessler, Caroline Kruse, Andrew D. Leavitt, Alfred I. Lee, Howard A. Liebman, Adrian C. Newland, Ashley E. Ray, Michael D. Tarantino, Jecko Thachil, David J. Kuter, Douglas B. Cines, James B. Bussel

Blood (2022) 139 (10): 1564–1574.

https://doi.org/10.1182/blood.2021013411

Published: 2022

Includes: Supplemental data

Journal Articles

LUNA3 Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Oral BTK Inhibitor Rilzabrutinib in Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia

David J. Kuter, James B Bussel, Nichola Cooper, Terry Gernsheimer, Michele P. Lambert, Howard Liebman, Michael D Tarantino, Olga Bandman, Puneet Arora, Ann Neale, Regan Burns, Mengjie Yao, Waleed Ghanima

Blood (2021) 138 (Supplement 1): 1010.

https://doi.org/10.1182/blood-2021-144504

Published: 2021

Journal Articles

Updated Phase I/II Safety and Efficacy Results for Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed/Refractory Immune Thrombocytopenia

Blood (2021) 138 (Supplement 1): 14.

https://doi.org/10.1182/blood-2021-145128

Published: 2021

Journal Articles

How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment

Waleed Ghanima, Terry Gernsheimer, David J. Kuter

Blood (2021) 137 (20): 2736–2744.

https://doi.org/10.1182/blood.2021010968

Published: 2021

Journal Articles

Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial

Lynne Uhl, Susan F. Assmann, Taye H. Hamza, Ryan W. Harrison, Terry Gernsheimer, Sherrill J. Slichter

Blood (2017) 130 (10): 1247–1258.

https://doi.org/10.1182/blood-2017-01-757930

Published: 2017

Includes: Supplemental data

Journal Articles

A Platelet Count <50 x10 9 Was Not Associated with Increased Rates of Major Bleeding Among Anticoagulated Patients

Bethany T Samuelson, MD, Roland B. Walter, MD PhD, Terry Gernsheimer, MD, David A Garcia, MD

Blood (2016) 128 (22): 164.

https://doi.org/10.1182/blood.V128.22.164.164

Published: 2016

Journal Articles

Treatment of Bleeding in Severely Thrombocytopenic Patients with Transfusion of Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP) Is Safe - Report of a Phase 1 Dose Escalation Safety Trial

Sherrill J. Slichter, MD, Larry J. Dumont, PhD MBA, Jose A. Cancelas, MD PhD, Terry Gernsheimer, MD, Zbigniew Szczepiorkowski, MD PhD, Nancy M. Dunbar, MD, Stephen Medlin, DO, FACP, MeLinh Jones, B.S., Neeta Rugg, M.S., Gautham Prakash, B.S., Greggory J. Housler, MSc, MBA, Victor W. MacDonald, PhD, Peter Hmel, M.S., Janet H. Ransom, PhD

Blood (2016) 128 (22): 1030.

https://doi.org/10.1182/blood.V128.22.1030.1030

Published: 2016

Journal Articles

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

Blood (2013) 121 (14): 2596–2606.

https://doi.org/10.1182/blood-2012-07-442392

Published: 2013

Includes: Supplemental data

Journal Articles

How I treat thrombocytopenia in pregnancy

Terry Gernsheimer, Andra H. James, Roberto Stasi

Blood (2013) 121 (1): 38–47.

https://doi.org/10.1182/blood-2012-08-448944

Published: 2013

Journal Articles

Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP).

Terry Gernsheimer, MD, David J. Kuter, MD, DPhil, Douglas B. Cines, MD, Roberto Stasi, Mathias J. Rummel, MD, PhD, Bertrand Godeau, MD, Matthew Guo, PhD, Janet Franklin, MD, MPH

Blood (2010) 116 (21): 3701.

https://doi.org/10.1182/blood.V116.21.3701.3701

Published: 2010

Journal Articles

Platelet Counts Following Eltrombopag Discontinuation in Patients with Chronic Immune Thrombocytopenic Purpura.

Gregory Cheng, Michael Tarantino, MD, Terry Gernsheimer, MD, Oliver Meyer, Andres Brainsky, Nicole L. Stone

Blood (2009) 114 (22): 3517.

https://doi.org/10.1182/blood.V114.22.3517.3517

Published: 2009

Journal Articles

Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.

Gregory Cheng, Terry Gernsheimer, MD, Harold J. Olney, MD, CM, James B. Bussel, MD, Palvi Shah, Andres Brainsky, Kelly M. Grotzinger, Manuel Aivado

Blood (2009) 114 (22): 3522.

https://doi.org/10.1182/blood.V114.22.3522.3522

Published: 2009

Journal Articles

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Blood (2009) 113 (11): 2386–2393.

https://doi.org/10.1182/blood-2008-07-162503

Published: 2009

Journal Articles

Effects of Prophylactic Platelet (Plt) Dose on Transfusion (Tx) Outcomes (PLADO Trial)

Sherrill J. Slichter, MD, Richard M. Kaufman, MD, Susan F Assmann, PhD, Mark E. Brecher, MD, BC, Terry Gernsheimer, MD, Christopher D. Hillyer, MD, Jeffrey McCullough, MD, Ronald G. Strauss, MD, Darrell Triulzi, MD

Blood (2008) 112 (11): 285.

https://doi.org/10.1182/blood.V112.11.285.285

Published: 2008

Journal Articles

Evaluation of Bleeding and Thrombotic Events during Long-Term Use of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura.

Michael Tarantino, MD, Usha Sunkara, MD, James George, MD, Louis M. Aledort, MD, Matthew Guo, PhD, Dietmar Berger, MD, PhD, Terry Gernsheimer, MD

Blood (2008) 112 (11): 3422.

https://doi.org/10.1182/blood.V112.11.3422.3422

Published: 2008

Journal Articles

A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)

Michael D. Tarantino, James B. Bussel, Douglas B. Cines, Keith R. McCrae, Terry Gernsheimer, Howard A. Liebman, Wing-Yen Wong, Roshni Kulkarni, Eric Grabowski, Robert McMillan

Blood (2007) 109 (12): 5527.

https://doi.org/10.1182/blood-2006-03-004481

Published: 2007

Journal Articles

Standard of Care in Patients with Immune Thrombocytopenic Purpura: A Retrospective Chart Analysis.

Terry Gernsheimer, James Bussel, Elsa Lam, Joseph Leveque

Blood (2006) 108 (11): 3990.

https://doi.org/10.1182/blood.V108.11.3990.3990

Published: 2006

Journal Articles

Coagulopathy from Severe Postpartum Hemorrhage.

Andra H. James, MD, MPH, Michael Paglia, MD, PhD, Chad Grotegut, MD, Betty Thames, RN, BS, Terry Gernsheimer, MD

Blood (2006) 108 (11): 4145.

https://doi.org/10.1182/blood.V108.11.4145.4145

Published: 2006

Journal Articles

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

Sherrill J. Slichter, Kathryn Davis, Helen Enright, Hayden Braine, Terry Gernsheimer, Kuo-Jang Kao, Thomas Kickler, Edward Lee, Janice McFarland, Jeffrey McCullough, Glenn Rodey, Charles A. Schiffer, Robert Woodson

Blood (2005) 105 (10): 4106–4114.

https://doi.org/10.1182/blood-2003-08-2724

Published: 2005

NARROW

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

LUNA3 Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Oral BTK Inhibitor Rilzabrutinib in Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia

Updated Phase I/II Safety and Efficacy Results for Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed/Refractory Immune Thrombocytopenia

How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment

Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial

A Platelet Count <50 x10 9 Was Not Associated with Increased Rates of Major Bleeding Among Anticoagulated Patients

Treatment of Bleeding in Severely Thrombocytopenic Patients with Transfusion of Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP) Is Safe - Report of a Phase 1 Dose Escalation Safety Trial

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

How I treat thrombocytopenia in pregnancy

Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP).

Platelet Counts Following Eltrombopag Discontinuation in Patients with Chronic Immune Thrombocytopenic Purpura.

Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Effects of Prophylactic Platelet (Plt) Dose on Transfusion (Tx) Outcomes (PLADO Trial)

Evaluation of Bleeding and Thrombotic Events during Long-Term Use of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura.

A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)

Standard of Care in Patients with Immune Thrombocytopenic Purpura: A Retrospective Chart Analysis.

Coagulopathy from Severe Postpartum Hemorrhage.

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only